Panel Discussion: Leveraging Methylation-Based Liquid Biopsies to Deliver Earlier, More Actionable Trial Signals

• Where can methylation-based liquid biopsy create tangible impact in drug development today?
• Can methylation enable earlier and more confident clinical trial decision-making?
• What must happen for methylation to become embedded in mainstream clinical trial design?

Speakers:

William Pierceall

Executive Director, Early Oncology Translational Lead

Pfizer

Raluca Budiu-Predoiu

Director, Precision Medicine

Abbvie

Dishant Kalra

Head, Precision Medicine

Astellas Pharma

Rajiv Raja

Executive Director, Oncology Translational Medicine

GSK